Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:49 PM
Ignite Modification Date:
2025-12-24 @ 3:49 PM
NCT ID:
NCT00350792
Eligibility Criteria:
Inclusion Criteria:
* Pathologically confirmed Non Small Cell Lung Cancer Stage IIIb (not amenable to radiotherapy treatment) or Stage IV
* No previous chemotherapy for lung cancer
* Men and women \> or = 70 years
* At least one uni-dimensionally measurable lesion (Response Evaluation Criteria In Solid Tumors \[RECIST\]criteria)
* Eastern Cooperative Oncology Group (ECOG) Performance Status 0 to 1
Exclusion Criteria:
* Treatment within the last 30 days with a drug that has not received regulatory approval
* Serious systemic disorders
* Inability to discontinue administration of aspirin or anti-inflammatory non steroid
* Concurrent administration of any other antitumor therapy
* Brain metastasis
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
70 Years
Study:
NCT00350792
Study Brief:
Protocol Section:
NCT00350792